Clinical Trials Directory

Trials / Unknown

UnknownNCT03572270

HIV and Ovarian Reserve

Evaluation of the Potential Impact of HIV and Its Treatments on Ovarian Reserve: Prospective Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
University Hospital, Clermont-Ferrand · Academic / Other
Sex
Female
Age
18 Years – 37 Years
Healthy volunteers
Accepted

Summary

Recent evidence suggests a decline in fertility of persons living with HIV (PLWH) (delayed pregnancies, sponteanous abortions, especially when patients receive an antiretroviral therapy, early menopause, amenorrhea and anovulatory cycles) with a possible decrease in ovarian reserve. However, indications of fertility preservation by freezing oocytes are nevertheless not clearly identified. The objective of this study is to evaluate the ovarian reserve before and after the implementation of antiretroviral treatment in PLWH for whom the diagnosis of HIV has just been made.

Detailed description

This is a monocentric prospective cohort study with minimal risk and constraints. Ovarian reserve is compared between two groups: 30 PLWH, at time of diagnosis and 6, 12 and 18 months after initiation of an antiretroviral therapy, and 30 HIV negative women attending medically assisted procreation consultation for male infertility, age, BMI and smoking habits matched.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAMH testBlood test and pelvic ultrasound are performed at each visit to evaluate ovarian reserve
DIAGNOSTIC_TESTpelvic ultrasoundBlood test and pelvic ultrasound are performed at each visit to evaluate ovarian reserve

Timeline

Start date
2018-06-01
Primary completion
2022-06-01
Completion
2022-11-01
First posted
2018-06-28
Last updated
2018-06-28

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03572270. Inclusion in this directory is not an endorsement.